GSK grows pipeline with 35Pharma takeover, Frontier deal GSK CEO Luke Miels signs a pair of pipeline-expanding deals, and the first acquisition on his watch, as the group prepares for a looming patent cliff.

#GSK #35Pharma #pulmonaryarterialhypertension #PAH #heartfailure #FrontierBio #pharmalicensing #LukeMiels #siRNAtherapeutics #FrontierBiotech #HS235 #phase1 #clinicaltrials #heartfailurewithpreservedejectionfraction #HFpEF #bestinclasstherapy #activindirectedtherapy #INDstudies
zurl.co/9nkDQ